Chimeric Therapeutics Ltd
ASX:CHM
Chimeric Therapeutics Ltd
ASX:CHM
Price:
0.001
AUD
-50%
Market Closed
Market Cap:
AU$4.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
Jiangsu Lihua Animal Husbandry Co Ltd
SZSE:300761
|
CN |
|
R
|
Resintech Bhd
KLSE:RESINTC
|
MY |
|
Eagle Mountain Mining Ltd
ASX:EM2
|
AU |
|
Burford Capital Ltd
NYSE:BUR
|
GG |
|
CytomX Therapeutics Inc
NASDAQ:CTMX
|
US |
|
Kaival Brands Innovations Group Inc
NASDAQ:KAVL
|
US |
|
Banco Santander SA
NYSE:SAN
|
ES |
|
F
|
Fineqia International Inc
CNSX:FNQ
|
CA |
|
Electro Aco Altona SA
BOVESPA:EALT4
|
BR |
|
Traction AB
STO:TRAC B
|
SE |
|
A
|
Amrize AG
SIX:AMRZ
|
US |
|
S
|
STI Education Systems Holdings Inc
XPHS:STI
|
PH |
|
SiteOne Landscape Supply Inc
NYSE:SITE
|
US |
|
Ramsay Health Care Ltd
ASX:RHC
|
AU |
|
M Dias Branco SA Industria e Comercio de Alimentos
BOVESPA:MDIA3
|
BR |
|
R
|
R R Kabel Ltd
NSE:RRKABEL
|
IN |
|
OraSure Technologies Inc
NASDAQ:OSUR
|
US |
|
Wipro Ltd
NSE:WIPRO
|
IN |
|
Seino Holdings Co Ltd
TSE:9076
|
JP |
|
CTBC Financial Holding Co Ltd
TWSE:2891
|
TW |
|
Verditek PLC
LSE:VDTK
|
UK |
|
Hitech Group Australia Ltd
ASX:HIT
|
AU |
|
Gear4music Holdings PLC
LSE:G4M
|
UK |
Relative Value
The Relative Value of one
CHM
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.001 AUD,
Chimeric Therapeutics Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CHM Relative Value
HIDDEN
Multiples Across Competitors
CHM Competitors Multiples
Chimeric Therapeutics Ltd Competitors
Chimeric Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Chimeric Therapeutics Ltd
ASX:CHM
|
4.1m AUD | 1 | -0.2 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.6 | 35.1 | 35.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
